Xumin Zhou, Libin Zou, Hangyu Liao, Junqi Luo, Taowei Yang, Jun Wu, . . . Xiangming Mao. (2022). Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+ T cell-mediated ferroptosis in castration-resistant prostate cancer. Elsevier.
Chicago Style (17th ed.) CitationXumin Zhou, et al. Abrogation of HnRNP L Enhances Anti-PD-1 Therapy Efficacy via Diminishing PD-L1 and Promoting CD8+ T Cell-mediated Ferroptosis in Castration-resistant Prostate Cancer. Elsevier, 2022.
MLA (9th ed.) CitationXumin Zhou, et al. Abrogation of HnRNP L Enhances Anti-PD-1 Therapy Efficacy via Diminishing PD-L1 and Promoting CD8+ T Cell-mediated Ferroptosis in Castration-resistant Prostate Cancer. Elsevier, 2022.
Warning: These citations may not always be 100% accurate.